1. Home
  2. ESQ vs EVO Comparison

ESQ vs EVO Comparison

Compare ESQ & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Esquire Financial Holdings Inc.

ESQ

Esquire Financial Holdings Inc.

HOLD

Current Price

$109.72

Market Cap

941.0M

Sector

Finance

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.06

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESQ
EVO
Founded
2006
1993
Country
United States
Germany
Employees
N/A
4553
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
941.0M
1.1B
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
ESQ
EVO
Price
$109.72
$3.06
Analyst Decision
Buy
Strong Buy
Analyst Count
3
1
Target Price
$120.33
$7.00
AVG Volume (30 Days)
77.0K
47.1K
Earning Date
04-23-2026
04-08-2026
Dividend Yield
0.76%
N/A
EPS Growth
14.20
N/A
EPS
1.40
N/A
Revenue
N/A
N/A
Revenue This Year
$35.15
$1.37
Revenue Next Year
$39.09
$10.05
P/E Ratio
$78.29
N/A
Revenue Growth
N/A
N/A
52 Week Low
$87.54
$2.31
52 Week High
$119.86
$4.42

Technical Indicators

Market Signals
Indicator
ESQ
EVO
Relative Strength Index (RSI) 52.13 56.03
Support Level $103.31 $2.88
Resistance Level $111.41 $3.75
Average True Range (ATR) 2.81 0.07
MACD 0.36 0.01
Stochastic Oscillator 58.02 89.58

Price Performance

Historical Comparison
ESQ
EVO

About ESQ Esquire Financial Holdings Inc.

Esquire Financial Holdings Inc is a financial holding company operating as a full service commercial bank. It serves the financial needs of the litigation industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The bank offers tailored financial and payment processing solutions to the litigation community and their clients as well as dynamic and flexible payment processing solutions to small business owners. It operates in one operating segment, that of community banking.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: